June 2021
Volume 62, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2021
Multiscale clinicopathologic correlation of canonical and non-canonical intraretinal neovascularization in age-related macular degeneration (AMD)
Author Affiliations & Notes
  • Jeffrey D. Messinger
    Ophthalmology, 1. University of Alabama at Birmingham School of Medicine, Birmingham, Alabama, United States
  • Ling Chen
    Ophthalmology, 1. University of Alabama at Birmingham School of Medicine, Birmingham, Alabama, United States
    Ophthalmology, 2. First Affiliated Hospital of Chongqing Medical University China, Chongqing, Sichuan, China
  • Andreas Berlin
    Ophthalmology, 1. University of Alabama at Birmingham School of Medicine, Birmingham, Alabama, United States
    Ophthalmology, 3. University Hospital Würzburg Germany, Würzburg, Germany
  • Deepayan Kar
    Ophthalmology, 1. University of Alabama at Birmingham School of Medicine, Birmingham, Alabama, United States
  • Tommaso Bacci
    Ophthalmology, 4. Vitreous Retina Macula Consultants of New York, New York, New York, United States
  • Chandrakumar Balaratnasingham
    Ophthalmology, 5. Centre for Ophthalmology and Visual Science, University of Western Australia, Perth, Australia, Perth, Western Australia, Australia
    Ophthalmology, 7. Sir Charles Gairdner Hospital, Western Australia, Australia, Nedlands, Western Australia, Australia
  • Randev Mendes
    Ophthalmology, 8. Canberra Retina Clinic, Australia, Deakin, Western Australia, Australia
  • Daniela Ferrara
    9. Genentech, South San Francisco CA, San Francisco, California, United States
  • K Bailey Freund
    Ophthalmology, 4. Vitreous Retina Macula Consultants of New York, New York, New York, United States
    Ophthalmology, 10. LuEsther T. Mertz Retinal Research Center, Manhattan Eye, Ear and Throat Hospital, New York, NY, USA, New York, United States
  • Christine A Curcio
    Ophthalmology, 1. University of Alabama at Birmingham School of Medicine, Birmingham, Alabama, United States
  • Footnotes
    Commercial Relationships   Jeffrey Messinger, None; Ling Chen, None; Andreas Berlin, None; Deepayan Kar, None; Tommaso Bacci, None; Chandrakumar Balaratnasingham, None; Randev Mendes, None; Daniela Ferrara, Genentech (E), Roche (I); K Bailey Freund, Allergan (C), Bayer (C), Genentech (C), Heidelberg Engineering (C), Novartis (C), Zeiss (C); Christine Curcio, Genentech (F), Heidelberg Engineering (F), Hoffman LaRoche (F), MacRegen Inc. (I)
  • Footnotes
    Support  Funding: This work was supported by Genentech/ Hoffman LaRoche, Heidelberg Engineering, The Macula Foundation, Inc., New York, NY; R01EY028282 (cac, dk); unrestricted funds to the Department of Ophthalmology and Visual Sciences (UAB) from Research to Prevent Blindness, Inc., and EyeSight Foundation of Alabama.
Investigative Ophthalmology & Visual Science June 2021, Vol.62, 654. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jeffrey D. Messinger, Ling Chen, Andreas Berlin, Deepayan Kar, Tommaso Bacci, Chandrakumar Balaratnasingham, Randev Mendes, Daniela Ferrara, K Bailey Freund, Christine A Curcio; Multiscale clinicopathologic correlation of canonical and non-canonical intraretinal neovascularization in age-related macular degeneration (AMD). Invest. Ophthalmol. Vis. Sci. 2021;62(8):654.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Purpose: Intraretinal macular neovascularization (MNV) is often preceded by hyperreflective foci (HRF) attributed to ectopic retinal pigment epithelium (RPE) and non-RPE. RPE migration may reflect a response to choroidal ischemia. We investigated with histology clinically documented HRF in fellow eyes, each with 3 MNV.

Methods : Methods: A white woman receiving anti-VEGF was monitored by optical coherence tomography (OCT) and angiography (OCT, dye-based) (OD, n=37; OS, n=6; last visits 3 and 2 months, respectively, before death). Eyes were recovered 4:05 hours after patient death at age 97 years. Eye-tracking (Heidelberg Engineering) aligned clinical and ex vivo imaging of the preserved eye prior to epoxy embedding for high-resolution light microscopic and transmission electron microscopic (TEM) investigation. Horizontally oriented 12 mm wide sections, 30 µm apart, were interleaved with 30 µm-thick slabs re-embedded for TEM.

Results :
Results: In OD, 2 MNV were investigated via TEM. In the first MNV, a hyperreflective triangle, with base-down and apex disrupting outer retinal and RPE layers correlated to an intraretinal vascular complex with numerous pericytes, ensheathed by collagenous material. Fully pigmented RPE distributed upward along this complex, entering but not contacting vessels. The complex rested on persistent basal laminar deposit overlying a completely calcified druse. Bruch’s membrane was intact. In the second MNV, a hyperreflective column atop a soft druse correlated to a column of RPE emerging from the top of intact RPE covering a lipid-rich druse. Cells at the column tip encircled a vessel dipping into the Henle fiber layer from the deep capillary plexus. Pericytes were not seen.

Conclusions :
Conclusion: The components and morphology of the first MNV resembled our recent description of treated type 3 MNV and added new observations of pericytes, and lack of penetration into the sub-RPE-BL space, which contained calcified drusen. The second MNV did not resemble the first MNV or others in either eye. It may represent another entity such as perifoveal exudative vascular anomalous complex (PEVAC; PMID 29079450), which is non-responsive to anti-VEGF. Recognition of different intraretinal MNV morphologies through clinicopathologic correlation may assist management decisions for neovascular AMD.

This is a 2021 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×